-
May 292025Tsuas yog ib txoj kev txhaj tshuaj ib hlis xwb! Ntev ntev ntev li lipid-txo, ...
Tsuas yog ib txoj kev txhaj tshuaj ib hlis xwb! Ntev ntev ntev li lipid-txo, theem 3 qhov tshwm sim zoo ntawm thawj zaug hauv chav kawm antisonucleide
-
May 272025Cov hauv paus ntsiab lus rau cov kuab tshuaj xaiv hauv cov txheej txheem kev ...
Cov hauv paus ntsiab lus rau cov kuab tshuaj xaiv hauv cov txheej txheem kev tshawb fawb keeb kwm kev tshawb fawb thiab kev txhim kho!
-
Apr 2720254 lub lim tiam ntawm cov ntshav siab txo! Tshiab me me molecules luam tawm ny...
4 lub lim tiam ntawm cov ntshav siab txo! Tshiab me me molecules luam tawm nyob rau hauv New England Journal Xov Xwm ntawm Tshuaj
-
Apr 212025Top 10 Yeeb Tshuaj Nrog Kev Psents tas los ntawm 2025
Top 10 Yeeb Tshuaj Nrog Kev Psents tas los ntawm 2025
-
Mar 192025Tshawb Nrhiav Tshiab: Kev Ntsuas Roj ntsha 502 Adhesive
Nyob rau hauv ib tug mysterious thiab loj ntuj ntuj ntiaj teb, lub marine orget hu ua "musel" yog renowned rau nws cov khoom lag luam zoo nkauj nyob h
-
Mar 112025Thawj tug! Kev kho mob lub tswv yim kev lees paub ntawm kev kho mob qhib
Thawj tug! Kev kho mob lub tswv yim kev lees paub ntawm kev kho mob qhib
-
Mar 072025Xwm: Cov Hom Phiaj Tshiab Cancer - CGRP
Xwm: Cov Hom Phiaj Tshiab Cancer - CGRP
-
Mar 042025Lub cim tshiab ntawm kev ua haujlwm poob phaus: semaglode
Lub cim tshiab ntawm kev ua haujlwm poob phaus: semaglode
-
Mar 032025Ntau tshaj 80% ntawm cov neeg mob ua tiav kev zam! Johnson & Johnson txoj kev...
Ntau tshaj 80% ntawm cov neeg mob ua tiav kev zam! Johnson & Johnson txoj kev tawm tsam kev tawm tsam mob cancer ua ke yuav tsum tau kev pom zoo hauv
-
Feb 272025Tshuaj Synthesis Txoj Kev Vafso (Vadadustat)
Tshuaj Synthesis Txoj Kev Vafso (Vadadustat)
-
Feb 262025Lub hnub yug thiab tseem ceeb ntawm cov tshuaj tshiab emblaveO
Lub Ob Hlis 4, 2025, Asmeskas Kev Tswj Xyuas Khoom Noj thiab Tshuaj FDA), muaj cov tshuaj tua kab mob uas tau pom zoo los ntawm AbbviMie tau tsim los
-
Feb 252025Gilead's breakthrough long-acting HIV therapy receives accelerated review in ...
Gilead's breakthrough long-acting HIV therapy receives accelerated review in Europe

